Disease relevance of Neoplasms, Basal Cell

• This article reviews human studies of basal cell cancer (BCC) and squamous cell cancer (SCC) and includes all studies identified in the published scientific literature investigating dietary exposure to fats, retinol, carotenoids, vitamin E, vitamin C, and selenium [1].
• OBJECTIVE: To document the problems of recurrent keratoses and basal cell cancers in patients following CO2 laser resurfacing [2].
• Forty-five squamous cell papillomas (SCP), 11 squamous cell cancers (SCC), and 27 basal cell cancers (BCC) were estimated [3].
• Significant therapeutic advances are also occurring with this class of drugs in some drug-resistant malignancies and several others that have become refractory, including advanced basal cell cancer, mycosis fungoides, melanoma, acute promyelocytic leukemia, and squamous cell carcinoma of the skin and of the head and neck [4].

High impact information on Neoplasms, Basal Cell

• PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer [5].
• Epithelial-stromal interactions in basal cell cancer: the PDGF system [6].
• Carcinoembryonic antigen in basal cell neoplasms in black patients: an immunohistochemical study [7].
• The antitumor effects of tretinoin were already demonstrated by 1974, when it was shown to cause regression in many basal cell cancers [8].
• For this purpose, we studied tissue arginase activity and ornithine level in tumor and adjacent normal tissues in 16 patients (55 +/- 10 years of age) with malignant skin tumors (8 of which were squamous cell cancers and 8 of which were basal cell cancers) [9].

Chemical compound and disease context of Neoplasms, Basal Cell

• The mean ornithine levels in squamous cell and basal cell cancers of the human skin were 42.45 +/- 19.10 nmol/mg protein and 39.33 +/- 10.19 nmol/mg protein, respectively [9].
• We injected intralesional bleomycin to eight new histologically proven basal cell cancers [10].

Gene context of Neoplasms, Basal Cell

• Molecular pathology in basal cell cancer with p53 as a genetic marker [11].
• The mean specific arginase activity levels in squamous cell and basal cell cancers of the human skin were 18.49 +/- 10.47 U/mg protein and 16.63 +/- 6.00 U/mg protein, respectively [9].

Analytical, diagnostic and therapeutic context of Neoplasms, Basal Cell

• RESULTS: Transplant recipients from the United States with skin malignancies were identified (n = 2018) and assigned to 1 of 3 groups: squamous cell cancer (SCC), basal cell cancer (BCC), or combined malignancies (BCC/SCC) [12].

References